(2)
Registration For This FREE Tribe Public Presentation and Q&A Event Is Now Open at NeuBase22.TribePublic.com
SAN FRANCISCO, CA / ACCESSWIRE / December 18, 2020 / Tribe Public announced today that Dietrich Stephan, Ph.D., Chief Executive Officer of NeuBase Therapeutics, Inc. (NASDAQ:NBSE), a biotechnology company accelerating the genetic revolution using a new class of synthetic medicines, will present at Tribe Public s Presentation and Q&A Webinar Event beginning at 8:30 a.m. PDT / 11:30 a.m. EDT on Tuesday, December 22, 2020.
During this complimentary, 30-minute event, Dr. Stephan will deliver his presentation titled Accelerating the Genetic Revolution with a New Class of Synthetic Medicines. He will also be available for a brief Q&A session. To register for the complimentary event, please visit